Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Hemostatic device for subcutaneous injection site

A subcutaneous injection and site-based technology, applied in the field of medical devices, can solve the problems of high incidence of adverse reactions, low medication compliance, and reduced patient medication compliance

Inactive Publication Date: 2018-06-15
TEDA INT CARDIOVASCULAR HOSPITAL
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In the clinical process, it was found that the reason for the low medication compliance of patients is that after the abdominal subcutaneous injection operation, the medical staff could not grasp the above-mentioned pressing force, pressing time and pressing depth well, resulting in the incidence of subcutaneous ecchymosis and other adverse reactions. Remains high, which leads to a decrease in patient medication compliance

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Hemostatic device for subcutaneous injection site

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0013] Below in conjunction with preferred embodiment, the specific implementation mode provided according to the present invention is described in detail as follows:

[0014] See the accompanying drawings for details. This embodiment provides a hemostatic device for subcutaneous injection sites, including a medical adhesive layer 1, a absorbent cotton layer 2, and a push self-locking mechanism 3. The push self-locking mechanism is placed in the central part of the medical adhesive layer. , the push self-locking mechanism includes a push self-locking cylinder 3-1 and a bottom surface support 3-2, the press self-locking cylinder is affixed to the center of the bottom surface support, and the end surface of the push self-locking cylinder contacting the patient's skin is affixed with a absorbent cotton layer . The self-locking distance of the self-locking cylinder moving vertically downward is 1 cm. The adhesive surface of the medical adhesive layer is provided with protective p...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a hemostatic device for a subcutaneous injection site. The hemostatic device is characterized by comprising a medical adhesive layer, an absorbent cotton layer and a pressingself-locking mechanism, the pressing self-locking mechanism is placed at the center of the medical adhesive layer and comprises a pressing self-locking cylinder and a bottom surface support, the pressing self-locking cylinder is fixed to the center of the bottom surface support, and the end face, contacting with the skin of a patient, of the pressing self-locking cylinder is fixedly connected withthe absorbent cotton layer. The hemostatic device has the advantages that after a medical worker completes injection, the pressing self-locking mechanism can keep the skin depressed by 1 cm, and thepressing depth, pressing force and pressing time of the patient can be accurately controlled to complete hemostasis by compression.

Description

technical field [0001] The invention belongs to medical equipment, in particular to a hemostatic device for subcutaneous injection site. Background technique [0002] Low-molecular-weight heparin is a new type of antithrombin Ⅲ (ATⅢ)-dependent antithrombotic drug, which is used for the treatment of various coronary heart diseases, acute myocardial infarction, thrombolysis or interventional therapy and postoperative routine anticoagulation and non-invasive treatment. Stabilize angina. Low-molecular-weight heparin is mostly injected subcutaneously in the abdomen, and the adverse reactions of injection are mainly subcutaneous bleeding and local pain at the injection site, which leads to a decrease in patients' medication compliance. Studies have found that when aspirin and other anticoagulant drugs are used at the same time, after injecting low molecular weight heparin, use a cotton swab to press vertically downward to make the skin sink by 1 cm, and the compression time shoul...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61B17/12
CPCA61B17/12009A61B2017/12004
Inventor 周佳仪顾淑芳
Owner TEDA INT CARDIOVASCULAR HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com